Gamma Investing LLC Kodiak Sciences Inc. Transaction History

Gamma Investing LLC

$1.17 Trillion
Q4 2024

A detailed history of Gamma Investing LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 68 shares of KOD stock, worth $544. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$544

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Jan 02, 2025	BUY	$2.6 - $10.9 $176 - $741	68 New	68 $677,000
Q1 2024 Apr 05, 2024	BUY	$3.01 - $7.45 $3,193 - $7,904	1,061 New	1,061 $5.58 Million

Others Institutions Holding KOD

# of Institutions

Shares Held

39M

Call Options Held

6.5K

Put Options Held

5.8K

Baker Bros. Advisors LP New York, NY

17.3M
Shares

$139 Million
0.48% of portfolio
Black Rock Inc. New York, NY

3.85M
Shares

$30.8 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.95M
Shares

$15.7 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

1.69M
Shares

$13.5 Million
0.0% of portfolio
Iconiq Capital, LLC San Francisco, CA

1.02M
Shares

$8.15 Million
0.06% of portfolio

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $417M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.

Account